CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2

被引:30
作者
Yang, Wensheng [1 ,2 ,3 ]
Dicker, David T. [1 ,2 ,3 ]
Chen, Jiandong [4 ]
El-Deiry, Wafik S. [1 ,2 ,3 ]
机构
[1] Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regulat, Dept Med Hematol Oncol,Abramson Comprehens Canc C, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regulat, Dept Pharmacol & Genet,Abramson Comprehens Canc C, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL USA
关键词
CARPs; MDM2; p53; 14-3-3; sigma; MDMX; HIF1; alpha; IGF-1;
D O I
10.4161/cc.7.5.5701
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CARP1 and CARP2 proteins (CARPs) are E3 ligases that target p53 as well as phospho-p53 for degradation. Because MDM2 is a critical regulator of p53 turnover, we investigated and found that CARPs associate with MDM2. We provide evidence that CARPs stabilize MDM2 by inhibiting MDM2 self-ubiquitination. CARPs together with MDM2 enhance p53 degradation, thereby inhibiting p53-mediated cell death. CARP protein levels correlate with MDM2 levels including under hypoxia where both are reduced. CARP2 was found to target 14-3-3 sigma for degradation, leading to MDM2 stabilization. MDMX, a homolog of MDM2, is not absolutely required for MDM2 stabilization by CARPs, although overexpression of CARP2 enhances MDM2/MDMX interaction. Taken together, our study identifies novel mechanisms by which CARP proteins regulate the p53 signaling pathway.
引用
收藏
页码:670 / 682
页数:13
相关论文
共 52 条
[1]   Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2α [J].
Akeno, N ;
Robins, J ;
Zhang, M ;
Czyzyk-Krzeska, MF ;
Clemens, TL .
ENDOCRINOLOGY, 2002, 143 (02) :420-425
[2]  
Alarcón R, 1999, CANCER RES, V59, P6046
[3]   Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53 [J].
Allende-Vega, N. ;
Saville, M. K. ;
Meek, D. W. .
ONCOGENE, 2007, 26 (29) :4234-4242
[4]   Hypophosphorylation of Mdm2 augments p53 stability [J].
Blattner, C ;
Hay, T ;
Meek, DW ;
Lane, DP .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (17) :6170-6182
[5]   Post-translational modification of p53 in tumorigenesis [J].
Bode, AM ;
Dong, ZG .
NATURE REVIEWS CANCER, 2004, 4 (10) :793-805
[6]   A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].
Bond, GL ;
Hu, WW ;
Bond, EE ;
Robins, H ;
Lutzker, SG ;
Arva, NC ;
Bargonetti, J ;
Bartel, F ;
Taubert, H ;
Wuerl, P ;
Onel, K ;
Yip, L ;
Hwang, SJ ;
Strong, LC ;
Lozano, G ;
Levine, AJ .
CELL, 2004, 119 (05) :591-602
[7]   An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 [J].
Boyd, SD ;
Tsai, KY ;
Jacks, T .
NATURE CELL BIOLOGY, 2000, 2 (09) :563-568
[8]   p53 ubiquitination: Mdm2 and beyond [J].
Brooks, CL ;
Gu, W .
MOLECULAR CELL, 2006, 21 (03) :307-315
[9]   Role of hypoxia-inducible factor (HIF)-1α-versus HIF-2α in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-1, or loss of von Hippel-Lindau function:: Implications for targeting the HIF pathway [J].
Carroll, Veronica A. ;
Ashcroft, Margaret .
CANCER RESEARCH, 2006, 66 (12) :6264-6270
[10]   ARF-BP1/mule is a critical mediator of the ARF tumor suppressor [J].
Chen, DL ;
Kon, N ;
Li, MY ;
Zhang, WZ ;
Qin, J ;
Gu, W .
CELL, 2005, 121 (07) :1071-1083